Omics Global Solutions (OGS) was born as a company whose objective is to be the platform for the development and commercialization of products related to OMICS sciences (proteomics, among others.) Associated with innovative projects that positively impact the lives of patients and medical professionals. Located in Puerto Rico (USA), its first milestone is the development, manufacture and commercialization of a test based on recently discovered biomarkers, to identify the risk of developing Diabetic Nephropathy. INNOVATIO ND2™ Focused on biotechnology, our mission is to develop and commercialize clinical prognostic products based on novel scientific models, addressing the unmet needs of physicians and patients. Having as main strength; an extensive commercial experience in Latin America and direct ties with the United States, we remain committed to high quality standards, bringing science to the community.